Induction of heat-shock protein 70 by prostaglandin A1 inhibits HIV-1 Vif-mediated degradation of APOBEC3G

Antiviral Research

Volumn 99, Issue 3, 2013, Pages 307-311

  Sugiyama, Ryuichi ^a,b   Abe, Makoto ^a   Nishitsuji, Hironori ^a,c   Murakami, Yuko ^a   Takeuchi, Hiroaki ^d   Takaku, Hiroshi ^a  

^a CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c National Center for Global Health and Medicine   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antiviral; APOBEC3G; Heat shock protein; Human immunodeficiency virus; Prostaglandin A1; Viral infectivity factor

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HEAT SHOCK PROTEIN 70; PROSTAGLANDIN A1; UBIQUITIN; ANTIGEN P24; GAG PROTEIN; PROTEASOME; VIF PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE; PROSTAGLANDIN A; ANTIVIRUS AGENT; VIRAL INFECTIVITY FACTOR;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; ANTIVIRAL ACTIVITY; CELL LYSATE; CONTROLLED STUDY; ENZYME DEGRADATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS TITRATION; WILD TYPE; CELL LINE; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HIV INFECTIONS; METABOLISM; PHYSIOLOGY; UPREGULATION; VIROLOGY; DRUG EFFECT; HEAT-SHOCK PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROSTAGLANDIN A(1);

ANTI-HIV AGENTS; CELL LINE; CYTIDINE DEAMINASE; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROSTAGLANDINS A; PROTEOLYSIS; UP-REGULATION; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANTIVIRAL; APOBEC3G; HEAT-SHOCK PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS; PROSTAGLANDIN A(1); VIRAL INFECTIVITY FACTOR;

EID: 84884577867     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.06.017     Document Type: Article

References (31)

1. Amici C., Santoro M.G. Suppression of virus replication by prostaglandin A is associated with heat shock protein synthesis. J. Gen. Virol. 1991, 72(Pt 8):1877-1885.
2. Ankel H., Mittnacht S., Jacobsen H. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon. J. Gen. Virol. 1985, 66(Pt 11):2355-2364.
3. Barouch D.H. Challenges in the development of an HIV-1 vaccine. Nature 2008, 455:613-619.
4. Carattoli A., Fortini D., Rozera C., Giorgi C. Inhibition of HIV-1 transcription by cyclopentenone prostaglandin A1 in Jurkat T lymphocytes. J. Biol. Regul. Homeost. Agents 2000, 14:209-216.
5. D'Onofrio C., Alvino E., Garaci E., Bonmassar E., Santoro M.G. Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures. Br. J. Cancer 1990, 61:207-214.
6. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
7. Hayes M.M., Lane B.R., King S.R., Markovitz D.M., Coffey M.J. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J. Biol. Chem. 2002, 277:16913-16919.
8. Hirayama E., Hattori M., Kim J. Specific binding of heat shock protein 70 with HN-protein inhibits the HN-protein assembly in Sendai virus-infected Vero cells. Virus Res. 2006, 120:199-207.
9. Iwatani Y., Chan D.S., Wang F., Maynard K.S., Sugiura W., Gronenborn A.M., Rouzina I., Williams M.C., Musier-Forsyth K., Levin J.G. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 2007, 35:7096-7108.
10. Kobayashi M., Takaori-Kondo A., Miyauchi Y., Iwai K., Uchiyama T. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J. Biol. Chem. 2005, 280:18573-18578.
11. Mehle A., Goncalves J., Santa-Marta M., McPike M., Gabuzda D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 2004, 18:2861-2866.
12. Mercenne G., Bernacchi S., Richer D., Bec G., Henriet S., Paillart J.C., Marquet R. HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation. Nucleic Acids Res. 2010, 38:633-646.
13. Nathans R., Cao H., Sharova N., Ali A., Sharkey M., Stranska R., Stevenson M., Rana T.M. Small-molecule inhibition of HIV-1 Vif. Nat. Biotechnol. 2008, 26:1187-1192.
14. Robb M.L. Failure of the Merck HIV vaccine: an uncertain step forward. Lancet 2008, 372:1857-1858.
15. Rossi A., Elia G., Santoro M.G. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 1997, 94:746-750.
16. Sakai A., Hirabayashi Y., Aizawa S., Tanaka M., Ida S., Oka S. Investigation of a new p24 antigen detection system by the chemiluminescence-enzyme-immuno-assay. Kansenshogaku Zasshi 1999, 73:205-212.
17. Santoro M.G. Antiviral activity of cyclopentenone prostanoids. Trends Microbiol. 1997, 5:276-281.
18. Santoro M.G., Benedetto A., Carruba G., Garaci E., Jaffe B.M. Prostaglandin A compounds as antiviral agents. Science 1980, 209:1032-1034.
19. Santoro M.G., Jaffe B.M., Garaci E., Esteban M. Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells. J. Gen. Virol. 1982, 63:435-440.
20. Santoro M.G., Jaffe B.M., Esteban M. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. J. Gen. Virol. 1983, 64(Pt 12):2797-2801.
21. Santoro M.G., Favalli C., Mastino A., Jaffe B.M., Esteban M., Garaci E. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus. Arch. Virol. 1988, 99:89-100.
22. Santoro M.G., Garaci E., Amici C. Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc. Natl. Acad. Sci. USA 1989, 86:8407-8411.
23. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
24. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 2003, 9:1404-1407.
25. Stopak K., de Noronha C., Yonemoto W., Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 2003, 12:591-601.
26. Sugiyama R., Nishitsuji H., Furukawa A., Katahira M., Habu Y., Takeuchi H., Ryo A., Takaku H. Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G. J. Biol. Chem. 2011, 286:10051-10057.
27. Yamamoto N., Fukushima M., Tsurumi T., Maeno K., Nishiyama Y. Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2. Biochem. Biophys. Res. Commun. 1987, 146:1425-1431.
28. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
29. Yu Y., Xiao Z., Ehrlich E.S., Yu X., Yu X.F. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 2004, 18:2867-2872.
30. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
31. Zuo T., Liu D., Lv W., Wang X., Wang J., Lv M., Huang W., Wu J., Zhang H., Jin H., Zhang L., Kong W., Yu X. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC. J. Virol. 2012, 86:5497-5507.